|
CYP2C8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.723000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.969600E-02 |
| Normal-vs-Stage2 |
8.990200E-01 |
| Normal-vs-Stage3 |
5.930800E-01 |
| Normal-vs-Stage4 |
5.472000E-01 |
| Stage1-vs-Stage2 |
3.230000E-01 |
| Stage1-vs-Stage3 |
4.794300E-02 |
| Stage1-vs-Stage4 |
9.214300E-02 |
| Stage2-vs-Stage3 |
6.418200E-01 |
| Stage2-vs-Stage4 |
5.680800E-01 |
| Stage3-vs-Stage4 |
8.482400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.710400E-01 |
| Normal-vs-AfricanAmerican |
7.515200E-01 |
| Normal-vs-Asian |
2.585800E-01 |
| Caucasian-vs-AfricanAmerican |
9.915000E-01 |
| Caucasian-vs-Asian |
4.525000E-01 |
| AfricanAmerican-vs-Asian |
6.064200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.825780E-01 |
| Normal-vs-Female |
4.904600E-01 |
| Male-vs-Female |
3.706800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.139220E-01 |
| Normal-vs-Age(41-60Yrs) |
5.922000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.896600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.016800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.705800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.289990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.867600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.265800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.194600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.691800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.58360000000113E-05 |
| Classical-VS-Follicular |
1.558360E-01 |
| Classical-VS-Other |
5.048400E-01 |
| Classical-VS-Normal |
2.713800E-01 |
| Tall-VS-Follicular |
2.03289999999301E-05 |
| Tall-VS-Other |
2.738400E-01 |
| Tall-VS-Normal |
1.821460E-04 |
| Follicular-VS-Other |
6.044400E-01 |
| Follicular-VS-Normal |
5.220100E-02 |
| Other-VS-Normal |
4.575600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.270000E-01 |
| Normal-vs-N1 |
2.088800E-01 |
| N0-vs-N1 |
4.287600E-01 |
|
|
